Abstract
The potential of a novel LHRH antagonist, TX54, to inhibit reproductive function in male rats was evaluated. After subcutaneous injection at a dosage of 200 μg/rat, once a week for 2 weeks, all the drug-treated male rats maintained mating behavior. But, only one out of seven female rats mated to treated males was pregnant with two fetuses. At the end of medication, sperm count and motility of caudal epididymal spermatozoa of the treated rats were reduced significantly (TX54 vs. control: 11.3 ± 3.2 × 10 8/mg epididymal plasma, 66.4 ± 13.4% vs. 18.4 ± 2.4 × 10 8/mg epididymal plasma, 83.0 ± 2.7%). Suppression of serum testosterone by TX54 was not observed 48 h after drug injection and at the end of experiment. Morphological examination revealed that at the IX stage of seminiferous epithelium cycle, spermiation was impaired in TX54-treated rats. Less elongated spermatids were found in the lumen of seminiferous tubules of the treated rats. The size of Leydig cells decreased; pycnosis and apoptosis features occurred.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
